Heart attack and stroke lead to over half a million deaths in the United States annually. It is now possible to predict these cardiovascular events well in advance using a number of biomarkers related to vascular structure and function. Collecting such noninvasive biomarkers as part of the All of Us cohort will allow us to fine-tune this timeline prediction.